Structure Therapeutics
GPCR
16.13
-0.99
-5.78%
Structure Therapeutics
US · GPCR
#2815 by market cap
Listed 2023
16.13
-0.99
-5.78%
Periodic snapshot; not a real-time feed.
· 2026-11-20 19:30
About Structure Therapeutics
Structure Therapeutics, Inc. is a clinical stage global biopharmaceutical company, which engages in developing novel oral therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its pipeline includes Aleniglipron GSBR-1290, ACCG-2671, GIPR, GCGR, ANPA-0073, and LTSE-2578. The company was founded by Raymond C. Stevens in 2016 and is headquartered in South San Francisco, CA.
- Founded
- 2016
- CEO
- Professor Raymond C. Stevens, PhD
- Employees
- 220
- Headquarters
- South San Francisco, California, United States of America
- Fiscal year end
- 12-31
- Website
- structuretx.com
Company profile
- Exchange
- US
- Symbol
- GPCR
- Market-cap rank
- #2815
- Listing date
- 2023-02-03
- Market cap
- 1.15B
- Float cap
- 894.95M
- Shares out
- 71.59M
- Float shares
- 55.48M
Sectors & themes
Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.
Structure Therapeutics discussion 0 comments